drugset
drugset / Trial / NCT02682524

Phase IV Clinical Trial to Evaluate the Efficacy and Safety of PlbCR and Aceclofenac in the Treatment of Patients With Osteoarthritis of the Knee

NCT02682524 ↗

Phase 4 Completed 191 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

A multicenter, randomized, double-blinded, parallel, active-controlled, phase IV clinical trial to evaluate the efficacy and safety of PlbCR and aceclofenac in the treatment of patients with osteoarthritis of the knee

Timeline

Start
2015-08
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aceclofenac Small molecule 100 mg —
Comparator Pelubiprofen Small molecule 45 mg —

Indications

osteoarthritis, knee